Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Vanda Pharmaceuticals acquires tachykinin NK1 receptor antagonist

April 17, 2012

New vaccine shows promise to treat drug addiction

April 13, 2012

Nippon Shinyaku seeks approval of drug for persons with alcohol dependence

March 27, 2012

NME protects human bone marrow progenitor cells against radiation

March 15, 2012

Immunovaccine and Weill Cornell Medical College join to develop anticocaine vaccine

March 13, 2012

Researchers in U.S. design new therapeutics for radiation injury

March 9, 2012

Courtagen and Avaxia join forces to create new assay

March 8, 2012

Tekmira Pharmaceuticals adds new RNAi therapeutic to pipeline

March 5, 2012

BioDelivery Sciences and FDA agree on BEMA-buprenorphine/naloxone development plan

Feb. 29, 2012

SGX-202 shows promise in model of gastrointestinal acute radiation syndrome

Feb. 22, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...